… Treatment of viral fulminant myocarditis … interleukin-1 in myocardial inflammation and
contractile dysfunction, we treated a patient with fulminant viral myocarditis with the interleukin-1 …

… -1 blockade in a case of fulminant myocarditis. The patient had developed fulminant myocarditis
… treatment options for fulminant myocarditis beyond mechanical support, we evaluated IL-…

… This direct beneficial effect of IL-1 inhibition on contractile function explains in part the
near-instant clinical improvement observed in life-threatening cases of fulminant myocarditis, …

… Table 1shows the individual baseline data of patients with fulminant myocarditis included
in this study. A viral study was performed in nine patients by measurement of neutralizing …

… biological activity of interleukin-1 alpha and beta (IL-1ß) by competitive inhibition of IL-1
binding to … Thus we report our experience of eight children with acute fulminant myocarditis who …

… -19 have high concentrations of interleukin (IL)-1 beta, interferon (IFN) gamma, IFN-inducible
protein (IP)-10, and monocyte chemoattractant protein (MCP)-1. It has been shown that …

… fulminant myocarditis. These findings indicate that IL-10 might be a useful prognostic marker
in patients with fulminant myocarditis, … in patients with fulminant myocarditis than in severely …

… Anakinra has shown to improve cardiac function in case reports of patients with fulminant
myocarditis.ARAMIS (Anakinra Versus Placebo for the Treatment of Acute Myocarditis) is the …

… Direct cytolysis of myocytes caused by the initial viral infection in stage 1 is thought to be
particularly important in fulminant myocarditis. Early and extensive loss of myocytes and …

… of concurrent FT1D and fulminant viral myocarditis. Parainfluenza-… and fulminant myocarditis.
(Int Heart J 2015; 56: 239-244) … Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac …